These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 20440848)

  • 1. Connection between inflammation and carcinogenesis in gastrointestinal tract: focus on TGF-beta signaling.
    Hong S; Lee HJ; Kim SJ; Hahm KB
    World J Gastroenterol; 2010 May; 16(17):2080-93. PubMed ID: 20440848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor-beta in cancer and metastasis.
    Jakowlew SB
    Cancer Metastasis Rev; 2006 Sep; 25(3):435-57. PubMed ID: 16951986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of the Transforming Growth Factor-β Signaling Pathway in Gastrointestinal Cancers.
    Matsuoka T; Yashiro M
    Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-β signaling in liver and gastrointestinal cancers.
    Katz LH; Likhter M; Jogunoori W; Belkin M; Ohshiro K; Mishra L
    Cancer Lett; 2016 Sep; 379(2):166-72. PubMed ID: 27039259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-beta: recent advances on its role in immune tolerance.
    Mantel PY; Schmidt-Weber CB
    Methods Mol Biol; 2011; 677():303-38. PubMed ID: 20941619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic suppression of inflammation blocks the tumor-promoting effects of TGF-β in gastric tissue.
    Ota M; Horiguchi M; Fang V; Shibahara K; Kadota K; Loomis C; Cammer M; Rifkin DB
    Cancer Res; 2014 May; 74(9):2642-51. PubMed ID: 24590056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role for transforming growth factor-beta (TGF-beta) in human cancer.
    Gold LI
    Crit Rev Oncog; 1999; 10(4):303-60. PubMed ID: 10654929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The genetic landscapes of inflammation-driven gastrointestinal tract cancers.
    Wang Y; Yan M; Or PM; Chan AM
    Curr Pharm Des; 2015; 21(21):2924-41. PubMed ID: 26004418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-β Signaling in Cancer.
    Syed V
    J Cell Biochem; 2016 Jun; 117(6):1279-87. PubMed ID: 26774024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGF-β in Inflammatory Bowel Diseases: A Tale of the Janus-Like Cytokine.
    Shen Y; Zhang C; Chen Y
    Crit Rev Eukaryot Gene Expr; 2015; 25(4):335-47. PubMed ID: 26559094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights into mechanisms of gastrointestinal inflammation and cancer.
    Ward SG; Mrsny R
    Curr Opin Pharmacol; 2009 Dec; 9(6):677-9. PubMed ID: 19857997
    [No Abstract]   [Full Text] [Related]  

  • 12. Transforming growth factor-β in the gastrointestinal and hepatic tumor microenvironment.
    Achyut BR; Yang L
    Gastroenterology; 2011 Oct; 141(4):1167-78. PubMed ID: 21839702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF-beta and colorectal carcinogenesis.
    Roman C; Saha D; Beauchamp R
    Microsc Res Tech; 2001 Feb; 52(4):450-7. PubMed ID: 11170304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duel nature of TGF-beta signaling: tumor suppressor vs. tumor promoter.
    Bachman KE; Park BH
    Curr Opin Oncol; 2005 Jan; 17(1):49-54. PubMed ID: 15608513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of transforming growth factor-beta 1 receptor type II occur in ulcerative colitis-associated carcinomas, sporadic colorectal neoplasms, and esophageal carcinomas, but not in gastric neoplasms.
    Souza RF; Garrigue-Antar L; Lei J; Yin J; Appel R; Vellucci VF; Zou TT; Zhou X; Wang S; Rhyu MG; Cymes K; Chan O; Park WS; Krasna MJ; Greenwald BD; Cottrell J; Abraham JM; Simms L; Leggett B; Young J; Harpaz N; Reiss M; Meltzer SJ
    Hum Cell; 1996 Sep; 9(3):229-36. PubMed ID: 9183654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A central role for the JNK pathway in mediating the antagonistic activity of pro-inflammatory cytokines against transforming growth factor-beta-driven SMAD3/4-specific gene expression.
    Verrecchia F; Tacheau C; Wagner EF; Mauviel A
    J Biol Chem; 2003 Jan; 278(3):1585-93. PubMed ID: 12426318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-β1 in carcinogenesis, progression, and therapy in cervical cancer.
    Zhu H; Luo H; Shen Z; Hu X; Sun L; Zhu X
    Tumour Biol; 2016 Jun; 37(6):7075-83. PubMed ID: 27010470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble recombinant human thrombomodulin suppresses inflammation-induced gastrointestinal tumor growth in a murine peritonitis model.
    Amada E; Fukuda K; Kumagai K; Kawakubo H; Kitagawa Y
    Mol Cell Biochem; 2020 Dec; 475(1-2):195-203. PubMed ID: 32767229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress in inflammation-based gastrointestinal tract diseases: challenges and opportunities.
    Kim YJ; Kim EH; Hahm KB
    J Gastroenterol Hepatol; 2012 Jun; 27(6):1004-10. PubMed ID: 22413852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-beta signaling in cancer treatment.
    Fabregat I; Fernando J; Mainez J; Sancho P
    Curr Pharm Des; 2014; 20(17):2934-47. PubMed ID: 23944366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.